Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer
Condition(s):Breast CancerLast Updated:October 27, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:October 27, 2023Recruiting
Condition(s):Colpomycosis; Bacterial Vaginosis; Mixede VaginitisLast Updated:December 11, 2023Recruiting
Condition(s):High Risk Cancer; Pancreatic CancerLast Updated:September 5, 2023Recruiting
Condition(s):Skin Condition; Hair Fragility; Nails, IngrownLast Updated:March 12, 2024Recruiting
Condition(s):Acute Myeloid Leukemia, AdultLast Updated:February 9, 2024Not yet recruiting
Condition(s):Advanced Malignant Solid TumorsLast Updated:September 13, 2023Recruiting
Condition(s):Leukemia, Acute Lymphocytic (ALL); Leukemia, Acute Myelogenous (AML); Myelodysplastic SyndromesLast Updated:March 15, 2024Recruiting
Condition(s):Pain, JointLast Updated:May 11, 2022Not yet recruiting
Condition(s):Metastatic MelanomaLast Updated:September 6, 2022Recruiting
Condition(s):Diabetic Foot UlcersLast Updated:January 3, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.